Premium Stock Market Articles
In order to access all blog posts, including premium content, please Subscribe!Featured Stocks in Action — week of November 23, 2015 (Nov. 27th update; 9:58 PM MT update)
You must be an active subscriber to view this premium content. Subscribe or Login.
read morePfizer to Buy Allergan for $160 Billion
by Crista Huff President, Goodfellow LLC Chief Analyst, Smart Investing in Turbulent Times Global pharmaceutical company Allergan PLC (AGN, $302.56), maker of Viagra, has agreed to be acquired by global biopharmaceutical company Pfizer Inc. (PFE, $31.27), in a transaction valued at $160 billion. Allergan PLC will keep its Irish domicile, and change its name to Pfizer PLC. The company will thereafter no longer be required to pay U.S. income taxes. The merger is targeted to close in the second half of 2016. AGN shareholders will received...
read moreMonday’s Buy List — week of November 23, 2015
You must be an active subscriber to view this premium content. Subscribe or Login.
read moreFeatured Stocks in Action — week of November 16, 2015 (Nov. 19th update, 9:58 PM MT)
You must be an active subscriber to view this premium content. Subscribe or Login.
read moreDefense Stocks Are Da Bomb
You must be an active subscriber to view this premium content. Subscribe or Login.
read moreBe Prepared to Profit from Financial Stocks in 2016!
You must be an active subscriber to view this premium content. Subscribe or Login.
read moreFeatured Stocks in Action — week of November 9, 2015 (Nov. 13th update, 8:45 AM MT)
You must be an active subscriber to view this premium content. Subscribe or Login.
read moreThis Aggressive Growth Stock Benefits From Rising Interest Rates
You must be an active subscriber to view this premium content. Subscribe or Login.
read moreMonday’s Buy List — week of November 9, 2015
You must be an active subscriber to view this premium content. Subscribe or Login.
read moreFeatured Stocks in Action — week of November 2, 2015 (Nov. 5th update @ 7:44 PM MT)
You must be an active subscriber to view this premium content. Subscribe or Login.
read more
